The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Tumour progression and the nature of cancer
Open accessAbstract
The nature of neoplasia and its sometime end result, cancer, has been studied by exposition and explanation of the sequential lesions of tumour progression. Neoplastic lesions were divided into four classes on the basis of growth characteristics and whether lesional growth is confined to one or more tissue compartments. Class IA, the initial lesion, an orderly, probably clonal growth, usually differentiates and disappears. Class IB: Failure to differentiate accompanied by disorderly growth. Class IC: Randomly dispersed atypical cells, constituting a precursor state. Class II, intermediate lesions, apparently arising from the atypical cells, show temporally unrestricted growth within the tissue compartment of origin. Class III lesions, primary invasive cancers, show temporally unrestricted growth in two or more tissue compartments and metastasise along different paths, a property associated with extracellular matrix interaction. The metastatic pathways may result from different subsets of cells in the primary cancer. Class IV lesions are the metastases. It was concluded that, all neoplasms develop in the same way, have the same general behavioural characteristics, and, when malignant, all interact with the extracellular matrix of the primary and the secondary sites. The origins and development of cancer are considered to be pluralistic and not due to a discrete change in a cell, whose progeny, as a result of that discrete change, carries all of the information required to explain the almost limitless events of a neoplastic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
How does the extracellular matrix direct gene expression?
Bissell, M. J., Hall, H. G., & Parry, G. (1982) · Journal of Theoretical Biology · doi:10.1016/0022-5193(82)90388-5 · Cited by 1,522
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Self-citationA study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
Clark, W. H., Elder, D. E., Guerry, D., Epstein, M. N., Greene, M. H., & Van Horn, M. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80310-x · Cited by 975
Self-citationNicolson, G. L. (1987) · PubMed · Cited by 502
Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988) · PubMed · Cited by 474
High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
GREENE, M. H., CLARK, W. H., TUCKER, M. A., KRAEMER, K. H., ELDER, D. E., & FRASER, M. C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-458 · Cited by 455
Self-citationThe Cellular Basis of Site-Specific Tumor Metastasis
Flier, J. S., Underhill, L. H., & Zetter, B. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003013220907 · Cited by 349
Human Cell Hybrids: Analysis of Transformation and Tumorigenicity
Stanbridge, E. J., Der, C. J., Doersen, C.-J., Nishimi, R. Y., Peehl, D. M., Weissman, B. E., & Wilkinson, J. E. (1982) · Science · doi:10.1126/science.7053574 · Cited by 340
Biology of tumor progression in human melanocytes.
Herlyn, M., Clark, W. H., Rodeck, U., Mancianti, M., Jambrosic, J., & Koprowski, H. (1987) · PubMed · Cited by 236
Self-citationCancer as a dynamic developmental disorder.
Rubin, H. (1985) · PubMed · Cited by 214
Masri, G. D., Clark, W. H., Guerry, D., Halpern, A., Thompson, C. J., & Elder, D. E. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70149-c · Cited by 180
Self-citationTumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes
Holzmann, B., Bröcker, E. B., Lehmann, J. M., Ruiter, D. J., Sorg, C., Riethmüller, G., & Johnson, J. P. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390410 · Cited by 170
Rs, K., Waghorne, C. G., Korczak, B. M., Lagarde, A., & Ml, B. (1988) · PubMed · Cited by 104
Edelman, G. M. (1989) · Scientific American · doi:10.1038/scientificamerican0589-76 · Cited by 98
Rhodes, A. R., Seki, Y., Fitzpatrick, T. B., & Stern, R. S. (1988) · Cancer · doi:10.1002/1097-0142(19880115)61:2<358::aid-cncr2820610227>3.0.co;2-# · Cited by 50
Human cutaneous malignant melanoma as a model for cancer
Clark, W. H. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00049406 · Cited by 33
Self-citationReview Article: Biology of Melanoma Invasion and Metastasis
Liotta, L. A., Guirguis, R., & Stracke, M. L. (1987) · Pigment Cell Research · doi:10.1111/j.1600-0749.1987.tb00528.x · Cited by 28
Cited by
Cytokine therapeutics: lessons from interferonalpha.
Gutterman, J. U. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1198 · Cited by 703
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
MacDougall, J. R., & Matrisian, L. M. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690603 · Cited by 419
Hu, Q., Gao, M., Feng, G., & Liu, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408897 · Cited by 419
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Metadata
- Authors
- Clark, W.
- Venue
- British Journal of Cancer
- Published
- 1991-10
- Volume
- 64
- Issue
- 4
- Pages
- 631-644
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1999083651
- Cited by
- 282
- References
- 19
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.